Terence M. Williams named radiation oncology chair at City of Hope

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Terence M. Williams was named professor and chair of City of Hope’s Department of Radiation Oncology.

Williams is tasked with expanding clinical and basic science research in the department. He will also integrate and expand novel treatment therapies, provide professional development and advancement opportunities for radiation oncology physicians, expand the Radiation Oncology Residency Program and build on the department’s financial performance.

Previously, Williams held several leadership roles at The James Cancer Hospital and Comprehensive Cancer Center at The Ohio State University. Most recently, he served as vice chair of translational research, associate professor of radiation oncology and division director of the Thoracic and Hepatopancreaticobiliary clinical programs.

Williams specializes in treating patients with thoracic and gastrointestinal cancers, with a particular emphasis on non-small cell lung cancer, pancreatic cancer and hepatobiliary malignancies.

His laboratory-based, NIH-funded research focuses on DNA damage response pathways, DNA repair and novel mechanisms of sensitization to radiation and other genotoxic therapies and nutrient scavenging through caveolae-mediated endocytosis.

Table of Contents

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login